Marlena Walls

Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design

Ping Wei, Marlena Walls, Ming Qiu et al. · Molecular Cancer Therapeutics · 2010 · 194 citations · Full text

Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design

Hengmiao Cheng, Chunze Li, Simon Bailey et al. · ACS Medicinal Chemistry Letters · 2012 · 78 citations · Full text

Drug Target, Pharmaceutical Chemistry, Empirical Scaling Tool +18

Highly Selective and Potent Thiophenes as PI3K Inhibitors with Oral Antitumor Activity

Kevin Liu, JinJiang Zhu, Graham L. Smith et al. · ACS Medicinal Chemistry Letters · 2011 · 39 citations · Full text

Pi3k Inhibitors, Pharmacotherapy, Pharmaceutical Chemistry +20

Targeting Small Cell Lung Cancer Harboring <i>PIK3CA</i> Mutation with a Selective Oral PI3K Inhibitor PF-4989216

Marlena Walls, Sangita M. Baxi, Pramod P. Mehta et al. · Clinical Cancer Research · 2013 · 33 citations · Full text

Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth

Xinqiang Huang, Jill Magnus, Vivek Kaimal et al. · Molecular Cancer Therapeutics · 2017 · 21 citations